Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001704400-19-000001
Filing Date
2019-05-17
Accepted
2019-05-17 11:07:35
Documents
1
Effectiveness Date
2019-05-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8289
  Complete submission text file 0001704400-19-000001.txt   9309
Mailing Address 300 TECHNOLOGY SQUARE, SUITE 400 CAMBRIDGE MA 02130
Business Address 300 TECHNOLOGY SQUARE, SUITE 400 CAMBRIDGE MA 02130 617-441-7200
Anelixis Therapeutics, Inc. (Filer) CIK: 0001704400 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: D | Act: 33 | File No.: 021-339827 | Film No.: 19834686